"
Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases"
written by Priyadarshini Biswal, Susmita Behera, Asaranti Kar, Dilleswari Pradhan, Pradeep Kumar Behera, Subrat Burma, Chandraprava Mishra,
published by
International Journal of Clinical Medicine,
Vol.6 No.12, 2015
has been cited by the following article(s):
[1]
|
Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
|
|
2023 |
|
|
[2]
|
Immunohistochemical Study on Hormone Receptors and HER2 Status in Invasive Breast Carcinoma and its Therapeutic Implications
|
|
2019 |
|
|
[3]
|
Comparison of fine needle aspiration cytology and core needle biopsy findings with excisional biopsy in breast malignancy
|
|
2019 |
|
|
[4]
|
Prognostic subtyping based on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor2 expression in breast cancer cases among north Indian females
|
|
International Journal of Community Medicine and Public Health,
2018 |
|
|
[5]
|
Prognostic subtyping based on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor2 expression in breast cancer …
|
|
2018 |
|
|
[6]
|
Clinicopathological and immunohistological profile of infiltrating ductal carcinoma breast in a tertiary care centre of western UP-A study of 100 cases
|
|
2018 |
|
|
[7]
|
Incidence, Epidemiology and Clinico-Pathological Status of Different Molecular Subtypes of Breast Cancer in NICRH, Dhaka
|
|
Delta Medical College Journal,
2018 |
|
|
[8]
|
Correlation between hormonal receptor status and Her 2 neu expression with the age of breast cancer patients and its outcome: a single institutional study in Egypt
|
|
Cancer Biology,
2017 |
|
|
[9]
|
STATUS OF KI67 INDEX AND TP53 GENE EXPRESSION IN PRIMARY BREAST CARCINOMA: AN IMMUNOHISTOCHEMICAL ASSESSMENT
|
|
2017 |
|
|
[10]
|
Correlation of Expression of ER, PR with the onset age, histopathological grading, size of tumor and metastatic behavior of invasive duct cell carcinoma breast
|
|
2016 |
|
|
[1]
|
Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
Medical Journal of Dr. D.Y. Patil Vidyapeeth,
2022
DOI:10.4103/mjdrdypu.mjdrdypu_187_21
|
|
|
[2]
|
Role of immunohistochemical markers in breast cancer and their correlation with grade of tumour, our experience
International Clinical Pathology Journal,
2018
DOI:10.15406/icpjl.2018.06.00175
|
|
|